Form 4: Zimmer Biomet SVP Lori Winkler Reports Stock Transactions
SEC Form 4 Filing
Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., reports the acquisition and disposal of company stock and restricted stock units.
Summary
- On March 5, 2025, Lori Winkler sold 1,443 shares of Zimmer Biomet common stock at a price of $104.4 per share.
- On March 6, 2025, Winkler acquired 1,757 shares of common stock through the vesting of restricted stock units (RSUs).
- Also on March 6, 2025, 692 shares were withheld by Zimmer Biomet to satisfy tax obligations related to the vesting of RSUs at a price of $104.86.
- Following these transactions, Winkler beneficially owns 9,833 shares of common stock and 1,756 restricted stock units.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard SEC filing reporting stock transactions.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at Zimmer Biomet.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent a small portion of the overall outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Sale of 1,443 shares of common stock. |
| 03/06/2025 | Acquisition of 1,757 shares through RSU vesting and withholding of 692 shares for taxes. |
| 03/06/2026 | Remaining RSUs vest. |
| 03/07/2025 | Date of the report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.